--(BUSINESS WIRE)--Wolters Kluwer (AEX:WKL):
What: Pharmacy Next: Safer, Affordable & Personalized, a Wolters Kluwer-hosted online panel of medical, retail pharmacy, and pharmacogenomics experts predicting the future of prescription medications and pharmacy as healthcare delivery decentralizes across the care continuum.
The panel will discuss what patient safety risks are emerging with prescription medicines in tomorrow’s more distributed care models, whether patient trust and outcomes will improve as prescribing roles evolve, and how health consumers’ medication costs can be contained. Plus, as innovative precision medicines spread, are Americans open to pharmacogenomic testing to match them with treatments more uniquely personalized to their individual genetics?
Pharmacy Next panelists will also discuss surprising results from a new Wolters Kluwer consumer survey that foreshadows massive shifts in who Americans trust for medication prescribing, worries, as well as the trade-offs consumers are willing to accept for lower drug costs.
When: Thursday, November 3, 2022, at 11 a.m. EDT
Where: This is a live online event with attendee Q&A. Registration is free and can be accessed here. Attendees who join the live event will be the first to receive an executive summary of the new Pharmacy Next consumer survey followed by an in-depth report in January 2023.
Who: Peter Bonis, MD, Chief Medical Officer at Wolters Kluwer, will introduce the Pharmacy Next panel. Daniel Streetman, PharmD, of the Metabolism, Interactions, and Genomics group at Wolters Kluwer, will moderate the discussion.
Pharmacy Next panelists include:
- David Bates, MD, an internationally renowned expert on patient safety from Brigham and Women’s Hospital and Harvard Medical School
- Daniel Knecht, MD, VP and Chief Clinical Innovation Officer at CVS Caremark
- Jill Kolesar, PharmD, an expert in pharmacy practice and precision medicine from the University of Kentucky School of Pharmacy
Register to attend the live Pharmacy Next panel here.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2021 annual revenues of €4.8 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,800 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.
